Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q1 2026 Earnings Call Transcript May 7, 2026
Amylyx Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.37 EPS, expectations were $-0.34.
Operator: Good morning. My name is Kate, and I will be your conference operator today. At this time, I would like to welcome everyone to the Amylyx Pharmaceuticals First Quarter 2026 Earnings Conference Call. [Operator Instructions] Please be advised that this call is being recorded at the...
